Navigation Links
FDA Seeks Comment on Proposed Guidelines for High-Quality Clinical Studies
Date:8/15/2011

SILVER SPRING, Md., Aug. 15, 2011 /PRNewswire-USNewswire/ -- The FDA today issued draft guidance to help researchers and manufacturers design better quality clinical studies in support of premarket approval (PMA) applications for medical devices.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Manufacturers submit PMA applications for high-risk (class III) medical devices. These applications undergo the most stringent type of FDA device review. PMA submissions include data from pivotal clinical studies which the FDA uses, along with other information, in determining approval.

The proposed guidance outlines agency expectations for clinical trial design issues such as minimizing data bias and variability, setting appropriate study objectives, selecting the appropriate type of study, and choosing study sites and study participants.

It is one of 25 action items listed in the FDA's Plan of Action for Implementation of 510(k) and Science Recommendations announced earlier this year to enhance predictability and transparency of regulatory pathways and to strengthen the 510(k) process.

"We want to help manufacturers and researchers take the least burdensome approach to getting safe and effective products to market, said Jeffrey Shuren, M.D., director of the FDA's Center for Devices and Radiological Health. "This guidance will help manufacturers and researchers better understand the FDA's basic expectations for clinical trials. We encourage researchers to contact the FDA to discuss the most practical approach to studying their device."

The evidence needed to support a PMA application varies depending on the medical device. But today's draft guidance can help manufacturers and researchers design a pivotal study that is a practical investment of time, effort, and resources and has a high likelihood of demonstrating safety and effectiveness.

Although this guidance is developed primarily for clinical studies used to support PMAs, the recommendations of this guidance may also be used in designing clinical studies used to support 510(k) submissions.

For more information:

CDRH Plan of Action for 510(k) and Science

http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHReports/ucm239448.htm

Draft Guidance for Industry, Clinical Investigators, and Food and Drug Administration Staff: Design Considerations for Pivotal Clinical Investigations for Medical Devices http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm265553.htm

FDA: Medical Devices

http://www.fda.gov/MedicalDevices/default.htm

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Media Inquiries: Karen Riley, 301-796-4674, karen.riley@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA


'/>"/>
SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Seymour Hospital Seeks to Meet Meaningful Use Requirements With Prognosis ChartAccess® Comprehensive EHR
2. Warner Chilcott Seeks to Refinance its Existing Credit Agreement
3. FDA Seeks to Invest in Foodborne Illness Prevention, Medical Product Safety and Countermeasures
4. The Welcome Back Awards Seeks Nominations to Honor Leaders in the Depression Community
5. Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278
6. Study Seeks Volunteers to Measure Safety of Treatment Boost for Patients with Oropharyngeal Cancer
7. Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer
8. We Keep Moving Project Seeks Stories of People Across the Country Living With and Affected by MS
9. Sigma-Aldrich Announces SAGE(TM) Priority Partners Program; Seeks Researchers to Evaluate New Knockout Rat Models
10. New Legislation Seeks to Boost Participation in Clinical Trials for Rare Diseases
11. Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... 27, 2016  Hologic, Inc. (Nasdaq: ... for the fiscal second quarter ended March 26, ... $0.24 increased 41.2%, and non-GAAP diluted EPS of ... 5.8% on a reported basis, and 6.3% on ... posted another good quarter, highlighted by 14.6% growth ...
(Date:4/27/2016)... , le 27 Avril 2016 ... a progressé de +5% sur le trimestre, soutenu ... de consommables  Croissance de +16% des ... Mauna Kea Technologies (Euronext : MKEA, FR0010609263 ; ... confocale laser, annonce aujourd,hui son chiffre d,affaires pour ...
(Date:4/27/2016)... 2016 Elekta today announced that ... be the focal point of seven scientific presentations at ... for Radiotherapy & Oncology, taking place April 29 - ... radiotherapy system and a high-field MRI scanner with sophisticated ... patient,s anatomy in real time. The MR-linac is designed ...
Breaking Medicine Technology:
(Date:5/1/2016)... Mission Viejo, CA (PRWEB) , ... May 01, 2016 , ... ... plan for those in need of chiropractic help. The agency offers a verity of ... and any chiropractic need. According to Chris Nelson at the firm, “Many insurance plans ...
(Date:4/30/2016)... ... April 30, 2016 , ... The Hacking Medicine Institute ... to critically evaluate and rank health-focused applications and connected devices for better disease ... unbiased and accurate information to help accelerate patient and provider adoption of clinically ...
(Date:4/30/2016)... ... , ... well is a challenge for all of us, but there are things we can do to ... “Research is showing more and more that there are simple, yet important steps that can ... age.” Top priorities Dr. Kohli’s recommends for her patients include;, , exercise ...
(Date:4/29/2016)... Angeles, CA (PRWEB) , ... April 29, 2016 , ... ... Mirmelli, a mother and divorcee, shares her enthusiasm for Botox and lip injections, which ... the world famous youth oriented Coachella Valley Music and Arts Festival. The article explains ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Our bodies are ... way to confront and deal with these stressors is to adopt a more healthful ... good for you. Risa Groux, a certified Holistic Nutritionist and the creator of the ...
Breaking Medicine News(10 mins):